Shockwave Therapy for GTPS: Does It Work for Hip Bursitis?

What is GTPS?

Greater trochanteric pain syndrome (GTPS) is pain over the bony point on the side of your hip, the part you'd feel pressing on if you lay on that side. It's most often caused by tendinopathy of the gluteus medius and minimus tendons, which attach directly onto that bony point, rather than by true bursitis (inflammation of the fluid-filled sac that cushions the tendons). The older label "trochanteric bursitis" is still used loosely, but imaging studies repeatedly show the bursa itself is rarely the main problem, because it's the tendon that's degenerated and irritated. GTPS is considerably more common in women over 40, likely related to hip shape and loading patterns rather than anything correctable with rest alone.

Why GTPS is so stubborn

Gluteal tendons at the hip are compression-sensitive in a way that trips people up, similar in principle to how hamstring tendons near the sitting bone react badly to sustained compression. Everyday habits quietly aggravate it:

• Crossing your legs, which pulls the tendon directly onto the bony prominence.
• Standing with your hip "hung" on one side, the classic hip-jutted stance while queuing or chatting.
• Sleeping on the sore side without a pillow between the knees.
• Some stretching positions. Counterintuitively, stretching the outer hip often compresses the tendon further and can make things worse, not better.

This is why GTPS often drags on for months in people who are otherwise doing sensible things, since the compression triggers are easy to miss when they don't feel like "using" the hip.

What shockwave therapy is and how it's used for GTPS

Extracorporeal shockwave therapy (ESWT) delivers focused or radial acoustic pulses through the skin to the tendon over the outer hip. The aim is the same principle used at other tendon sites: stimulate blood flow and a healing response in tissue that's stalled in a degenerative, poorly-organised state, rather than a classically inflamed one. That is also why anti-inflammatory approaches tend to underwhelm here.

The evidence for GTPS specifically

A 2024 systematic review and meta-analysis of randomised controlled trials (eight RCTs, 754 patients) found ESWT gave meaningful short-term pain relief at two to four months, particularly with focused shockwave, though functional gains at six months, while present, didn't always reach a clinically important threshold. The authors positioned ESWT as a reasonable complement or alternative to corticosteroid injection and exercise therapy, while calling for more long-term comparative trials.

Head-to-head against corticosteroid injection, a 2023 single-blind randomised study found the two treatments performed comparably on pain and quality-of-life measures at three weeks and three months, with neither clearly beating the other. The practical difference is what each carries alongside it: corticosteroid is a single quick appointment, while shockwave avoids the tendon-weakening risk that comes with repeated steroid injections into a tendon that's already structurally compromised. For a condition this persistent, avoiding that cumulative risk is a genuine point in shockwave's favour.

What a course involves, and realistic timelines

• Sessions: typically 3 sessions, roughly a week apart, focused over the tender point at the side of the hip.
• During treatment: a probe delivers pulses directly over the bony prominence. Expect it to be uncomfortable in the moment given how superficial the tendon is there, easing once the session ends.
• Timeline: initial improvement often shows within 2–4 months; judge the full course over that window rather than after a single session.
• Alongside, not instead of, loading: trials generally test shockwave as an addition to activity modification, not as a stand-alone fix.
• Afterwards: a day or two of local soreness, redness or mild bruising is common and settles on its own. Some people notice a short flare before improvement.

Cost and availability in the UK

Shockwave for this condition is mostly a private treatment in the UK. Clinics commonly charge in the region of £60 to £120 per session, so a standard three-session course typically lands somewhere between £180 and £350, sometimes with the initial assessment charged separately. Prices vary widely by region and by whether focused or radial shockwave is used, so ask what the total course costs before booking rather than the per-session price alone.

NHS availability is patchy and depends on the local service. NICE reviewed the procedure in interventional procedures guidance on extracorporeal shockwave therapy for refractory greater trochanteric pain syndrome and concluded that the evidence on efficacy and safety was limited in quality and quantity, so it should be used only with special arrangements for clinical governance, consent and audit or research. In practice, that means it is offered in some musculoskeletal services and not others, and only for pain that has persisted despite first-line treatment. Patients should be told that symptoms can worsen and that pain during and after treatment is expected.

Who should not have shockwave therapy

• Pregnancy, where treatment near the area is avoided.
• Clotting disorders or anticoagulant medication, which raises bruising and bleeding risk. Discuss this before booking.
• Active infection, an open wound, or a known tumour at the treatment site.
• A recent corticosteroid injection into the same area, where most clinics wait around six weeks.
• Children and adolescents with open growth plates near the treatment site.
• Some implanted devices, which is worth flagging to the clinician at assessment.

Side effects in the trials are generally minor and short-lived: pain during treatment, temporary soreness, reddening of the skin and occasional bruising.

First-line alternatives usually tried first

Before shockwave enters the conversation, the standard first-line approach is a load-management and glute-strengthening programme, removing the compression triggers above and progressively strengthening the gluteus medius and minimus, exactly as in my glute strengthening programme. If lateral hip pain is new or you're not sure it's GTPS rather than a muscular or deep-rotator cause, my glute muscle pain guide covers the self-checks that tell them apart. Shockwave and corticosteroid injection are both typically considered once a genuine strengthening effort, usually 2–3 months, hasn't resolved things.

How I approach it in clinic

• Compression audit first. Crossed legs, hip-hung standing, sleep position. Fixing these often does more in the first fortnight than any hands-on treatment.
• Strength before injections or shockwave. Both have their place, but neither replaces the loading work the tendon actually needs long-term.
• Runners and hill walkers get particular attention. GTPS often flares when hill or speed work ramps up faster than glute strength can keep pace, a pattern covered from the training side in my colleagues' running injury prevention guide.
• A local assessment sorts the diagnosis out properly. If you're near Uckfield, the sports injury rehabilitation clinic can confirm GTPS in person and rule out other causes of lateral hip pain.

Common misconceptions I see in my patients

• "It's bursitis, so anti-inflammatories will fix it." In most GTPS, the bursa isn't the main problem, since it's a tendon-loading issue, which is why anti-inflammatory approaches alone so often underdeliver.
• "I should stretch the outer hip more." Stretching that position often adds compression to an already-compressed tendon and can flare things further, and this is one of the few places I actively advise against extra stretching.
• "An injection will sort it permanently." Steroid injections can give useful short-term relief, but repeated injections carry a tendon-weakening risk, and without addressing the compression habits and strength deficit, pain often returns.

FAQ: shockwave therapy for GTPS

Is GTPS the same as hip bursitis?

Not usually. GTPS is the umbrella term, and most cases turn out to be gluteus medius/minimus tendinopathy rather than true inflammation of the bursa, though the two labels are often used interchangeably in casual conversation.

Does shockwave therapy work for hip bursitis / GTPS?

Trial evidence is genuinely encouraging for short-term pain relief, particularly with focused shockwave, though six-month functional gains are more modest. It performs comparably to a corticosteroid injection in head-to-head trials, without the injection's cumulative tendon-weakening risk.

Should I try shockwave before strengthening exercises for GTPS?

No. A glute strengthening programme alongside removing compression triggers is first-line. Shockwave is a reasonable option once a genuine 2–3 month strengthening effort hasn't resolved symptoms.

Why does GTPS come back after an injection?

Because an injection treats the symptom, not the compression habits and tendon-strength deficit that caused it. Without addressing those, pain commonly returns once the injection's effect wears off.

How much does shockwave therapy cost in the UK?

Commonly £60 to £120 per session privately, so roughly £180 to £350 for a standard three-session course. Ask for the total course price including any assessment fee.

Is shockwave therapy available on the NHS for GTPS?

Sometimes, depending on your local musculoskeletal service. NICE advises it be used only with special arrangements for governance, consent and audit, and it is reserved for pain that has not settled with first-line treatment.

Does shockwave therapy hurt?

It is uncomfortable during the treatment itself, because the tendon sits close to the skin over a bony point, and it eases once the session ends. Expect a day or two of soreness afterwards.

How long does it take to work?

Initial improvement usually shows over two to four months rather than immediately. Judge the whole course over that window rather than after one session.

How many sessions will I need?

Typically three, about a week apart. Some protocols use up to five, and adding sessions beyond a standard course is not shown to add proportional benefit.